World's Best Scientists 2026 revealed!
Hematology, Transfusion and Cell Therapy
H-index 9

Hematology, Transfusion and Cell Therapy

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Immunology 238 14 21 3
Medicine 2642 90 214 8

Additional Metrics

Number of Best Scientists*: 206
Documents by Best Scientists*: 415
Top 100 Ranked Scientists*: 5
SCIMAGO H-index: 33
SCIMAGO SJR: 0.36
Impact Factor: 1.6

Overview

Top Research Topics at Hematology, Transfusion and Cell Therapy?

The journal tackles a plethora of topics, such as Gynecology, Internal medicine, Humanities, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and 2019-20 coronavirus outbreak. Some problems in Internal medicine that were presented in it overlapped with concepts under Gastroenterology and Oncology. The featured 2019-20 coronavirus outbreak research is covered under the field of Virology.

  • Gynecology (24.46%)
  • Internal medicine (16.14%)
  • Humanities (14.69%)

What are the most cited papers published in the journal?

  • Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. (65 citations)
  • Standardization and quality assessment for clinical grade mesenchymal stem cells from human adipose tissue (21 citations)
  • How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation. (21 citations)

Research areas of the most cited articles at Hematology, Transfusion and Cell Therapy:

The most cited papers mostly deal with topics like Virology, Internal medicine, Oncology, 2019-20 coronavirus outbreak and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The journal articles focus on Virology but the discussions also offer insight into other areas such as Reverse transcriptase, Blood transfusion and Microcephaly. In addition to 2019-20 coronavirus outbreak research, the most cited articles aim to explore topics under Value (mathematics) and Hemoglobin.

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Hematology, Transfusion and Cell Therapy (based on the number of publications) are:

  • Vanderson Rocha (26 papers) published 2 papers at the last edition, 22 less than at the previous edition,
  • Nelson Hamerschlak (20 papers) published 5 papers at the last edition, 8 less than at the previous edition,
  • André Rolim Belisário (18 papers) published 2 papers at the last edition, 13 less than at the previous edition,
  • Dimas Tadeu Covas (17 papers) published 3 papers at the last edition, 8 less than at the previous edition,
  • Katia Borgia Barbosa Pagnano (16 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Hematology, Transfusion and Cell Therapy (based on the number of publications) are:

  • University of São Paulo (135 papers) published 28 papers at the last edition, 52 less than at the previous edition,
  • State University of Campinas (68 papers) published 16 papers at the last edition, 17 less than at the previous edition,
  • Federal University of São Paulo (57 papers) published 12 papers at the last edition, 23 less than at the previous edition,
  • Universidade Federal de Minas Gerais (45 papers) published 9 papers at the last edition, 18 less than at the previous edition,
  • Federal University of Rio de Janeiro (37 papers) published 8 papers at the last edition, 17 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 27.73% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 41.86% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.56% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.19% of all publications and 31.40% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Further Application and Education Opportunities in Hematology, Transfusion, and Cell Therapy

With increasing advancements in the field of Hematology, Transfusion and Cell Therapy, there is a growing demand for skilled professionals to tackle complex health challenges. As research evolves, educational institutions continuously adapt their curriculum to maintain the relevance and applicability of their programs. This has led to the launch of various online courses and degree programs that cater to this demand. For instance, the best online nursing schools in North Carolina offer comprehensive courses that cover these complex subjects, helping learners gain the necessary skills to contribute to meaningful research and provide effective patient care.

Top Publications

  • Hemoglobin value may be decreased in patients with severe coronavirus disease 2019.

    Giuseppe Lippi;Camilla Mattiuzzi

    (2020)
    176 Citations
  • Isatuximab plus carfilzomib and dexamethasone vs. carfilzomib and dexamethasone in relapsed/refractory multiple myeloma (ikema): interim analysis of a phase 3, randomized, open-label study

    A. Maiolino;P. Moreau;M. Dimopoulos;J. Mikhael

    (2020)
    42 Citations
  • Validation of a formula predictive of peripheral blood stem cell yield and successful collection in healthy allogeneic donors.

    Cesar de Almeida-Neto;Vanderson Rocha;Frederico Rafael Moreira;Debora Toshie Hamasaki

    (2020)
    20 Citations
  • Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia

    Pablo Ferreira das Chagas;Graziella Ribeiro de Sousa;Márcio Hideki Kodama;Carlos Alberto Oliveira de Biagi Junior

    (2021)
    19 Citations
  • ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: ICARIA-MM SUBGROUP ANALYSIS

    (2020)
    16 Citations
  • UPDATED RESULTS FROM THE CARTITUDE-1 STUDY OF CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

    SZ Usmani;JG Berdeja;A Jakubowiak;M Agha

    (2021)
    16 Citations
  • Isatuximab plus carfilzomib and dexamethasone vs. carfilzomib and dexamethasone in relapsed/refractory multiple myeloma (ikema): interim analysis of a phase 3, randomized, open-label study

    (2020)
    12 Citations
  • Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival

    (2022)
    8 Citations
  • Stability of refrigerated whole blood samples for osmotic fragility test.

    Gian Luca Salvagno;Davide Demonte;Francesco Dima;Chiara Bovo

    (2020)
    8 Citations

Related Online Degrees & Career Pathways

For students interested in Medicine, there are several related online degrees that can broaden career opportunities while complementing traditional medical studies. For example, pursuing online phd programs in nursing offers an advanced pathway to specialize in patient care, leadership, and research without needing to be on campus. This flexibility is ideal for working professionals aiming to advance their careers.

Another growing field is health information management, where expertise in medical billing and coding is essential. Accredited online medical coding programs provide students with the skills to handle clinical data efficiently, an increasingly crucial role in healthcare administration.

For those with a background in biological sciences, numerous career options exist beyond clinical practice. Exploring the highest paying jobs with biology degree helps identify lucrative roles in research, biotech, and pharmaceuticals, which align well with medical knowledge.

Certification can further enhance career prospects, particularly for billing professionals. Understanding the differences between coding credentials, such as the ccs vs cpc salary, is important for making informed decisions on certification pathways and potential earnings in this specialized health sector.

Best Scientists Contributing to This Journal

Recently Published Articles